NDC 60429-739

NDC 60429-739

NDC 60429-739 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 60429-739
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 60429-739-05 [60429073905]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-05-17
Marketing End Date2017-01-02

NDC 60429-739-27 [60429073927]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-05-17
Marketing End Date2017-01-02

NDC 60429-739-90 [60429073990]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-05-17
Marketing End Date2017-01-02

NDC 60429-739-50 [60429073950]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-05-17
Marketing End Date2017-01-02

NDC 60429-739-01 [60429073901]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-05-17
Marketing End Date2017-01-02

NDC 60429-739-18 [60429073918]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090705
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2010-05-17
Marketing End Date2017-01-02

Drug Details

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.